4.7 Article

Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients

Felix S. Seibert et al.

Summary: Ubiquitous microthromboses in the pulmonary vasculature play a crucial role in the pathogenesis of COVID-19 associated acute respiratory distress syndrome (ARDS). Plasma exchange (PLEX) therapy can restore the balance between vWf and ADAMTS13, reduce inflammation, and improve ventilation parameters.

SCIENTIFIC REPORTS (2022)

Article Hematology

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

Ilaria Mancini et al.

Summary: Severe COVID-19 patients exhibit an increased risk of thromboembolic events, with evidence of microthrombosis in the lungs of deceased patients. The study found a significant alteration of the VWF-ADAMTS13 axis in COVID-19 patients, with an elevated VWF:Ag to ADAMTS13 activity ratio strongly associated with disease severity, enhancing the hypercoagulable state and risk of microthrombosis in these patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Critical Care Medicine

von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019

Adrian A. N. Doevelaar et al.

Summary: The study suggests that COVID-19 patients have significantly increased levels of von Willebrand factor, potentially leading to a relative deficiency of ADAMTS13 and the formation of large von Willebrand factor multimers, similar to thrombotic thrombocytopenic purpura. The ADAMTS13/von Willebrand factor antigen ratio is an independent predictor of disease severity and mortality, highlighting the potential use of plasma exchange as a therapeutic option and the inclusion of these factors in diagnostic workup for COVID-19.

CRITICAL CARE MEDICINE (2021)

Article Hematology

Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia

Ishac Nazy et al.

Summary: Our study excludes heparin-induced thrombocytopenia in critically ill COVID-19 patients and identifies platelet-activating immune complexes as a novel mechanism contributing to the disease.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Editorial Material Hematology

Thromboinflammation and the hypercoagulability of COVID-19

Jean M. Connors et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Gastroenterology & Hepatology

COVID-19-related thrombotic microangiopathy in a cirrhotic patient

A. Airoldi et al.

DIGESTIVE AND LIVER DISEASE (2020)

Article Infectious Diseases

Therapeutic plasma exchange in adults with severe COVID-19 infection

Faryal Khamis et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Letter Urology & Nephrology

Thrombotic microangiopathy in a patient with COVID-19

Kenar D. Jhaveri et al.

KIDNEY INTERNATIONAL (2020)

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Article Cell Biology

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Yu Zuo et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Letter Critical Care Medicine

Plasma exchange in critically ill COVID-19 patients

Christian Morath et al.

CRITICAL CARE (2020)

Article Hematology

Measurement of ADAMTS13 activity and inhibitors

T Miyata et al.

CURRENT OPINION IN HEMATOLOGY (2005)